PL1917246T3 - Pochodne benzochinazoliny i ich zastosowanie do leczenia chorób kości - Google Patents

Pochodne benzochinazoliny i ich zastosowanie do leczenia chorób kości

Info

Publication number: PL1917246T3
Authority: PL; Poland
Prior art keywords: bone disorders; treating bone; benzoquinazoline; derivatives; benzoquinazoline derivatives
Prior art date: 2005-08-15

Application number

PL06776845T

Other languages

English (en)

Inventor

Sandra Ammon

René Beerli

Leo Widler

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-15

Filing date

2006-08-14

Publication date

2010-04-30

2006-08-14 Application filed by Novartis Ag filed Critical Novartis Ag

2010-04-30 Publication of PL1917246T3 publication Critical patent/PL1917246T3/pl

Links

208000020084 Bone disease Diseases 0.000 title 1
PQIUGRLKNKSKTC-UHFFFAOYSA-N benzo[h]quinazoline Chemical class N1=CN=C2C3=CC=CC=C3C=CC2=C1 PQIUGRLKNKSKTC-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Other In-Based Heterocyclic Compounds (AREA)

PL06776845T 2005-08-15 2006-08-14 Pochodne benzochinazoliny i ich zastosowanie do leczenia chorób kości PL1917246T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0516723.4A GB0516723D0 (en)	2005-08-15	2005-08-15	Organic compounds
EP06776845A EP1917246B1 (en)	2005-08-15	2006-08-14	Benzoquinazoline derivatives and their use in treating bone disorders
PCT/EP2006/008036 WO2007020046A1 (en)	2005-08-15	2006-08-14	Benzoquinazoline derivatives and their use in treating bone disorders

Publications (1)

Publication Number	Publication Date
PL1917246T3 true PL1917246T3 (pl)	2010-04-30

Family

ID=35098331

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06776845T PL1917246T3 (pl)	2005-08-15	2006-08-14	Pochodne benzochinazoliny i ich zastosowanie do leczenia chorób kości

Country Status (34)

Country	Link
US (1)	US20100166765A1 (pl)
EP (1)	EP1917246B1 (pl)
JP (1)	JP2009505984A (pl)
KR (1)	KR20080043778A (pl)
CN (1)	CN101233112A (pl)
AR (1)	AR055606A1 (pl)
AT (1)	ATE448206T1 (pl)
AU (1)	AU2006281627B2 (pl)
BR (1)	BRPI0614544A2 (pl)
CA (1)	CA2619249A1 (pl)
CY (1)	CY1110247T1 (pl)
DE (1)	DE602006010401D1 (pl)
DK (1)	DK1917246T3 (pl)
EC (1)	ECSP088184A (pl)
ES (1)	ES2336484T3 (pl)
GB (1)	GB0516723D0 (pl)
GT (1)	GT200600372A (pl)
HR (1)	HRP20100072T1 (pl)
IL (1)	IL188922A0 (pl)
JO (1)	JO2585B1 (pl)
MA (1)	MA29742B1 (pl)
MX (1)	MX2008002163A (pl)
NO (1)	NO20081315L (pl)
NZ (1)	NZ565605A (pl)
PE (2)	PE20100239A1 (pl)
PL (1)	PL1917246T3 (pl)
PT (1)	PT1917246E (pl)
RU (1)	RU2416602C2 (pl)
SA (1)	SA06270266B1 (pl)
SI (1)	SI1917246T1 (pl)
TN (1)	TNSN08070A1 (pl)
TW (1)	TW200740758A (pl)
WO (1)	WO2007020046A1 (pl)
ZA (1)	ZA200800434B (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1831225A2 (en)	2004-11-19	2007-09-12	The Regents of the University of California	Anti-inflammatory pyrazolopyrimidines
EA200870409A1 (ru)	2006-04-04	2009-04-28	Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния	Антагонисты киназы pi3
EP1956019A1 (en) *	2007-01-22	2008-08-13	Novartis AG	Benzoquinazoline derivatives
AR068124A1 (es)	2007-08-30	2009-11-04	Novartis Ag	Derivados de fenil - isoquinolina y fenil - quinazolina
GB2467670B (en)	2007-10-04	2012-08-01	Intellikine Inc	Chemical entities and therapeutic uses thereof
CA2711558C (en)	2008-01-04	2016-12-13	Intellikine, Inc.	Phosphatidyl inositol-3 kinase inhibiting compounds
US8193182B2 (en)	2008-01-04	2012-06-05	Intellikine, Inc.	Substituted isoquinolin-1(2H)-ones, and methods of use thereof
JP5547099B2 (ja)	2008-03-14	2014-07-09	インテリカイン，エルエルシー	キナーゼ阻害剤および使用方法
US8993580B2 (en)	2008-03-14	2015-03-31	Intellikine Llc	Benzothiazole kinase inhibitors and methods of use
WO2010006072A2 (en)	2008-07-08	2010-01-14	The Regents Of The University Of California	Mtor modulators and uses thereof
AU2009268611B2 (en)	2008-07-08	2015-04-09	Intellikine, Llc	Kinase inhibitors and methods of use
JP5731978B2 (ja)	2008-09-26	2015-06-10	インテリカイン，エルエルシー	複素環キナーゼ阻害剤
WO2010042489A2 (en) *	2008-10-06	2010-04-15	Emory University	Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
CA2740885C (en)	2008-10-16	2018-04-03	The Regents Of The University Of California	Fused ring heteroaryl kinase inhibitors
US8476282B2 (en)	2008-11-03	2013-07-02	Intellikine Llc	Benzoxazole kinase inhibitors and methods of use
EP2380878B1 (en)	2009-01-19	2013-08-14	Daiichi Sankyo Company, Limited	Cyclic compound having hetero atom
EP2427195B1 (en)	2009-05-07	2019-05-01	Intellikine, LLC	Heterocyclic compounds and uses thereof
WO2011047384A2 (en)	2009-10-16	2011-04-21	The Regents Of The University Of California	Methods of inhibiting ire1
JP5654246B2 (ja) *	2010-03-03	2015-01-14	一般社団法人ファルマバレープロジェクト支援機構	キナゾリン化合物を有効成分とする医薬組成物
AU2011255218B2 (en)	2010-05-21	2015-03-12	Infinity Pharmaceuticals, Inc.	Chemical compounds, compositions and methods for kinase modulation
JP2013545749A (ja)	2010-11-10	2013-12-26	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環化合物及びその使用
AU2012205669B2 (en)	2011-01-10	2015-08-20	Infinity Pharmaceuticals Inc.	Processes for preparing isoquinolinones and solid forms of isoquinolinones
JP6130305B2 (ja)	2011-02-23	2017-05-17	インテリカイン，エルエルシー	キナーゼ阻害剤の組み合わせおよびそれらの使用
US9056877B2 (en)	2011-07-19	2015-06-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
JP6027610B2 (ja)	2011-07-19	2016-11-16	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環式化合物及びその使用
EP2751093A1 (en)	2011-08-29	2014-07-09	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
MX370814B (es)	2011-09-02	2020-01-08	Univ California	Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US8828998B2 (en)	2012-06-25	2014-09-09	Infinity Pharmaceuticals, Inc.	Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
MX2015003874A (es)	2012-09-26	2015-12-16	Univ California	Modulacion de ire1.
KR102229478B1 (ko)	2012-11-01	2021-03-18	인피니티 파마슈티칼스, 인코포레이티드	Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
US8993555B2 (en)	2012-12-21	2015-03-31	Epizyme, Inc.	PRMT5 inhibitors and uses thereof
US9481667B2 (en)	2013-03-15	2016-11-01	Infinity Pharmaceuticals, Inc.	Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
PE20160685A1 (es)	2013-10-04	2016-07-23	Infinity Pharmaceuticals Inc	Compuestos heterociclicos y usos de los mismos
US9751888B2 (en)	2013-10-04	2017-09-05	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
SG10201808053XA (en)	2014-03-19	2018-10-30	Infinity Pharmaceuticals Inc	Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US20150320755A1 (en)	2014-04-16	2015-11-12	Infinity Pharmaceuticals, Inc.	Combination therapies
US9708348B2 (en)	2014-10-03	2017-07-18	Infinity Pharmaceuticals, Inc.	Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
US10160761B2 (en)	2015-09-14	2018-12-25	Infinity Pharmaceuticals, Inc.	Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
WO2017161116A1 (en)	2016-03-17	2017-09-21	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en)	2016-06-08	2021-02-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
MX391135B (es)	2016-06-24	2025-03-21	Infinity Pharmaceuticals Inc	Terapias de combinacion.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2525595A1 (fr) *	1982-04-27	1983-10-28	Pharmuka Lab	Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
JPH0769890A (ja) *	1993-06-29	1995-03-14	Takeda Chem Ind Ltd	キノリンまたはキナゾリン誘導体を含んでなる医薬組成物
US5958954A (en) *	1995-09-01	1999-09-28	Allergan Sales, Inc.	Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
RU2196137C2 (ru) *	1996-08-08	2003-01-10	Зенека Лимитед	Производные хиназолина и их применение в качестве ингибиторов фактора роста эндотелия сосудов
AR038658A1 (es) *	2001-06-15	2005-01-26	Novartis Ag	Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
GB0230015D0 (en) *	2002-12-23	2003-01-29	Novartis Ag	Organic compounds

2005
- 2005-08-15 GB GBGB0516723.4A patent/GB0516723D0/en not_active Ceased
2006
- 2006-08-09 SA SA6270266A patent/SA06270266B1/ar unknown
- 2006-08-11 GT GT200600372A patent/GT200600372A/es unknown
- 2006-08-11 AR ARP060103529A patent/AR055606A1/es not_active Application Discontinuation
- 2006-08-14 JO JO2006270A patent/JO2585B1/en active
- 2006-08-14 AU AU2006281627A patent/AU2006281627B2/en not_active Ceased
- 2006-08-14 DK DK06776845.7T patent/DK1917246T3/da active
- 2006-08-14 MX MX2008002163A patent/MX2008002163A/es active IP Right Grant
- 2006-08-14 PL PL06776845T patent/PL1917246T3/pl unknown
- 2006-08-14 JP JP2008526424A patent/JP2009505984A/ja active Pending
- 2006-08-14 CN CNA2006800283555A patent/CN101233112A/zh active Pending
- 2006-08-14 RU RU2008109654/04A patent/RU2416602C2/ru not_active IP Right Cessation
- 2006-08-14 DE DE602006010401T patent/DE602006010401D1/de active Active
- 2006-08-14 PE PE2010000013A patent/PE20100239A1/es not_active Application Discontinuation
- 2006-08-14 WO PCT/EP2006/008036 patent/WO2007020046A1/en not_active Ceased
- 2006-08-14 TW TW095129808A patent/TW200740758A/zh unknown
- 2006-08-14 US US12/063,526 patent/US20100166765A1/en not_active Abandoned
- 2006-08-14 BR BRPI0614544-2A patent/BRPI0614544A2/pt not_active IP Right Cessation
- 2006-08-14 PE PE2006000987A patent/PE20070419A1/es not_active Application Discontinuation
- 2006-08-14 PT PT06776845T patent/PT1917246E/pt unknown
- 2006-08-14 SI SI200630550T patent/SI1917246T1/sl unknown
- 2006-08-14 EP EP06776845A patent/EP1917246B1/en not_active Not-in-force
- 2006-08-14 HR HR20100072T patent/HRP20100072T1/hr unknown
- 2006-08-14 ES ES06776845T patent/ES2336484T3/es active Active
- 2006-08-14 AT AT06776845T patent/ATE448206T1/de active
- 2006-08-14 CA CA002619249A patent/CA2619249A1/en not_active Abandoned
- 2006-08-14 NZ NZ565605A patent/NZ565605A/en not_active IP Right Cessation
- 2006-08-14 KR KR1020087003565A patent/KR20080043778A/ko not_active Withdrawn
2008
- 2008-01-15 ZA ZA200800434A patent/ZA200800434B/xx unknown
- 2008-01-21 IL IL188922A patent/IL188922A0/en unknown
- 2008-02-13 MA MA30652A patent/MA29742B1/fr unknown
- 2008-02-14 TN TNP2008000070A patent/TNSN08070A1/en unknown
- 2008-02-14 EC EC2008008184A patent/ECSP088184A/es unknown
- 2008-03-12 NO NO20081315A patent/NO20081315L/no not_active Application Discontinuation
2010
- 2010-02-10 CY CY20101100130T patent/CY1110247T1/el unknown

Also Published As

Publication number	Publication date
SA06270266B1 (ar)	2010-06-07
ES2336484T3 (es)	2010-04-13
AU2006281627A1 (en)	2007-02-22
JO2585B1 (en)	2011-02-27
PE20100239A1 (es)	2010-04-12
TW200740758A (en)	2007-11-01
HRP20100072T1 (hr)	2010-03-31
MX2008002163A (es)	2008-04-22
IL188922A0 (en)	2008-08-07
WO2007020046A1 (en)	2007-02-22
CY1110247T1 (el)	2015-01-14
CA2619249A1 (en)	2007-02-22
KR20080043778A (ko)	2008-05-19
NZ565605A (en)	2011-03-31
EP1917246A1 (en)	2008-05-07
GB0516723D0 (en)	2005-09-21
PT1917246E (pt)	2010-02-12
MA29742B1 (fr)	2008-09-01
JP2009505984A (ja)	2009-02-12
AU2006281627B2 (en)	2010-11-04
BRPI0614544A2 (pt)	2011-04-05
DE602006010401D1 (de)	2009-12-24
RU2008109654A (ru)	2009-09-27
ECSP088184A (es)	2008-03-26
ZA200800434B (en)	2009-05-27
AR055606A1 (es)	2007-08-29
CN101233112A (zh)	2008-07-30
SI1917246T1 (sl)	2010-03-31
NO20081315L (no)	2008-05-15
ATE448206T1 (de)	2009-11-15
TNSN08070A1 (en)	2009-07-14
RU2416602C2 (ru)	2011-04-20
PE20070419A1 (es)	2007-04-23
GT200600372A (es)	2007-03-28
DK1917246T3 (da)	2010-03-29
EP1917246B1 (en)	2009-11-11
HK1117154A1 (en)	2009-01-09
US20100166765A1 (en)	2010-07-01

Publication	Publication Date	Title
ZA200800434B (en)	2009-05-27	Benzoquinazoline derivatives and their use in treating bone disorders
IL189578A0 (en)	2008-08-07	Pyridine derivatives and their use in the treatment of psychotic disorders
IL187444A0 (en)	2008-02-09	Tissue treatment device and method
ZA200806114B (en)	2009-11-25	Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
GB2423928B (en)	2008-04-09	Methods and compositions for treating pain
IL186963A0 (en)	2008-06-05	Methods and compositions for treating pain
IL184313A0 (en)	2007-10-31	4-(1h-indol-3-yl)-pyrimidin-2-ylamine derivates and their use in therapy
IL177717A0 (en)	2006-12-31	Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
IL178012A0 (en)	2006-12-31	Diphenyl-indol-2-on compounds and their use in the treatment of cancer
TWI349551B (en)	2011-10-01	Thiophenepyrimidinone derivatives and their use in therapy
IL191160A0 (en)	2008-12-29	Pyridopyrazine derivatives and use thereof
EP1922012A4 (en)	2014-12-24	METHOD AND DEVICE FOR VASCULAR PROTECTION IN SPINE SURGERY
PL1912650T3 (pl)	2018-01-31	Zastosowanie flibanseryny w leczeniu otyłości
AP2006003820A0 (en)	2006-12-31	Piperazin derivatives and their use in controllingpests
GB0523576D0 (en)	2005-12-28	Drug composition and its use in therapy
EP1890712A4 (en)	2012-08-15	COMPOSITIONS AND METHODS FOR TREATING PAIN
GB0405294D0 (en)	2004-04-21	Apparatus for use in orthopaedic surgery
IL185586A0 (en)	2008-01-06	1,2,4-triazine derivatives, preparation and use thereof in human therapy
EP1951682A4 (en)	2011-06-15	NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
EP1933853A4 (en)	2010-03-17	TREATMENT OF TISSUE DISTRACTION AND COMPOSITION FOR APPLYING THEREOF
IL185575A0 (en)	2008-01-06	Benzoxazocines and their therapeutic use
GB0509911D0 (en)	2005-06-22	Medical treatment aid for use in treating children
GB0803201D0 (en)	2008-04-02	Two-part dressing suitable for use in surgery
ZA200801548B (en)	2008-12-31	Pyridine derivatives and their use in the treatment of psychotic disorders
GB0511329D0 (en)	2005-07-13	Improvements in and relating to surgical implants